Mereo BioPharma Group

MREONasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$44.981 M

$0.28 -7.91%

Close of 6 Nov 2026

As of 6 Nov 2026, Mereo BioPharma Group (MREO) has a market capitalization of $45.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$500.0K

#3512 by revenue

Earnings

$41.9M

#1625 by earnings

Shares outstanding

798,454,864

Latest filing cover page

P/E ratio

1.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#342Citius OncologyCTOR$47.1M
#343Connect BiopharmaCNTB$46.0M
#344Mereo BioPharma GroupMREO$45.0M
#345Biomea FusionBMEA$42.6M
#346Gain TherapeuticsGANX$42.1M

What if Mereo BioPharma Group were worth as much as…

Open the what-if tool →

Gold $28.2T

$176,902.14

Per share 627,758× higher

Bitcoin $1.53T

$9,571.87

Per share 33,967× higher

Apple $5.02T

$31,423.55

Per share 111,510× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Mereo BioPharma Group are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.